2019
DOI: 10.1016/j.cpcardiol.2018.11.002
|View full text |Cite|
|
Sign up to set email alerts
|

Increasing Diversity in Clinical Trials: Overcoming Critical Barriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

12
456
2
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 479 publications
(506 citation statements)
references
References 26 publications
12
456
2
1
Order By: Relevance
“…Specifically, by incorporating FS limitations, the NHA model predicted that patients with APD were 1.5-times as likely to be admitted to a nursing home as patients with non-advanced PD, who were in turn 3-times as likely to be admitted to a nursing home relative to patients without PD. Because the MCBS data are nationally representative, these results are generalizable to the broader elderly population, with the caveat that the impact of treatment is based on clinical trial results in a controlled setting, not observational data 18,19 . A follow-on analysis after sufficient real-world LCIG data are available would be a welcome addition to these findings.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, by incorporating FS limitations, the NHA model predicted that patients with APD were 1.5-times as likely to be admitted to a nursing home as patients with non-advanced PD, who were in turn 3-times as likely to be admitted to a nursing home relative to patients without PD. Because the MCBS data are nationally representative, these results are generalizable to the broader elderly population, with the caveat that the impact of treatment is based on clinical trial results in a controlled setting, not observational data 18,19 . A follow-on analysis after sufficient real-world LCIG data are available would be a welcome addition to these findings.…”
Section: Discussionmentioning
confidence: 99%
“…Limitations to stratify public data with correlated demographic data and missing survival data in our cohort preclude definitive actionable clinical conclusions at this time. Although there are ongoing efforts to recruit minorities into existing clinical trials [86,87], these findings highlight the impactful possibilities of utilizing genetic ancestry in multi-ethnic cohorts and the need to demonstrate that variation within and among TNBC subtypes and how genetic ancestry may impact tumor biology, which in could guide treatment decisions. Author Contributions: UM, CY, and MD contributed to the concept, design, and generating; MD, CY, RM, ID, IA, and JW performed the data curation and analyses; IEE, ARF, WG, UM collected breast tissues; IEE, ARF, and WEG performed macro-dissections; MD, CY, RT, WDC, UM, and WG wrote and edited the manuscript.…”
Section: Discussionmentioning
confidence: 99%
“…Developing the knowledge, skills, and attitudes of inspectors so they can perform their jobs competently-safely, effectively, and efficiently-is important in any endeavor. When it comes to clinical trials involving human subjects, ensuring that international ethical principles are observed, that the rights, integrity and confidentiality of trial subjects are respected and protected, and that clinical trial data are collected in a reliable and valid manner, the competency of professional staff responsible with oversight of good clinical practices is exceptionally critical because failures can have devastating effects (Clark et al 2019;Eichler and Sweeney 2018).…”
mentioning
confidence: 99%